Anti-CCL18 antibody [EPR24781-84]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Anti-CCL18 antibody [EPR24781-84] is a Rabbit Monoclonal antibody that is used in CCL18 Dot Blot, IHC-P, Western Blot. Suitable for Human samples.
CCL18, also known as C-C motif chemokine ligand 18, CCL18, secreted by tumor-associated macrophages (TAMs), contributes to an immunosuppressive tumor microenvironment by recruiting regulatory T cells and other immunosuppressive cells. Elevated levels of CCL18 are linked to poor prognosis in various cancers, indicating a more aggressive tumor phenotype. This chemokine aids in cancer cell migration, invasion, and metastasis, promoting tumor progression. As a result, CCL18 is being explored as a therapeutic target to enhance the effectiveness of immunotherapies.
View Alternative Names
AMAC1, DCCK1, MIP4, PARC, SCYA18, CCL18, C-C motif chemokine 18, Alternative macrophage activation-associated CC chemokine 1, CC chemokine PARC, Dendritic cell chemokine 1, Macrophage inflammatory protein 4, Pulmonary and activation-regulated chemokine, Small-inducible cytokine A18, AMAC-1, DC-CK1, MIP-4
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Immunohistochemical analysis of paraffin-embedded Human stomach cancer tissue labelling CCL18 with ab300057 at 1/500 (0.982 μ/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Positive staining on human stomach cancer. The section was incubated with ab300057 at 4°C overnight. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Immunohistochemical analysis of paraffin-embedded A) HEK-293T cells transfected with human C-C motif chemokine 18 expression vector containing a myc-his tag, B) HEK-293T cells (untreated) labelling CCL18 with ab300057 at 1/200 (2.455 µg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Cytoplasmic staining on HEK-293T cells transfected with a human C-C motif chemokine 18 expression vector containing a myc-His tag (image A). No staining on HEK-293T cells untreated (image B). The section was incubated with ab300057 at 4°C overnight. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labelling CCL18 with ab300057 at 1/500 (0.982 µg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Positive staining on human tonsil. The section was incubated with ab300057 at 4°C overnight. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labelling CCL18 with ab300057 at 1/500 (0.982 μg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Positive staining on human tonsil. The section was incubated with ab300057 at 4°C overnight. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- WB
Supplier Data
Western blot - Anti-CCL18 antibody [EPR24781-84] (AB300057)
5% NFDM/TBST was used as blocking and diluting buffer and concentration. THP-1 cells after PMA and IL-4 treatment secrete high levels of CCL18. (PMID : 25502147).
All lanes:
Western blot - Anti-CCL18 antibody [EPR24781-84] (ab300057) at 1/1000 dilution
Lane 1:
THP-1( Human monocytic leukemia monocyte) treated with 0.1µg/ml PMA for 48 hours whole cell lysate at 50 µg
Lane 2:
THP-1 treated with 0.1µg/ml PMA for 48 hours, then with 0.045 µg/ml IL-4 added for 72 hours, whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 9 kDa
Observed band size: 10 kDa
false
Exposure time: 103s
- Dot
Supplier Data
Dot Blot - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Dot blot analysis of CCL18 using ab300057 at 1 : 1000 (0.491 µg/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution. Exposure time : 5.5 seconds Blocking and diluting buffer and concentration : 5% NFDM/TBST
- Dot
Supplier Data
Dot Blot - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Dot blot analysis of CCL18 using ab300057 at 1 : 1000 (0.491 µg/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution. Exposure time : 3 minutes Blocking and diluting buffer and concentration : 5% NFDM/TBST
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Immunohistochemical analysis of paraffin-embedded Human stomach cancer tissue labelling CCL18 with ab300057 at 1/500 (0.982 µ/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Positive staining on human stomach cancer. The section was incubated with ab300057 at 4°C overnight. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- WB
Supplier Data
Western blot - Anti-CCL18 antibody [EPR24781-84] (AB300057)
5% NFDM/TBST was used as blocking and diluting buffer and concentration.
THP-1 cells after PMA and IL-4 treatment secrete high levels of CCL18. (PMID : 25502147).
All lanes:
Western blot - Anti-CCL18 antibody [EPR24781-84] (ab300057) at 1/1000 dilution
Lane 1:
THP-1( Human monocytic leukemia monocyte) treated with 0.1µg/ml PMA for 48 hours whole cell lysate at 50 µg
Lane 2:
THP-1 treated with 0.1µg/ml PMA for 48 hours, then with 0.045 µg/ml IL-4 added for 72 hours, whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 10 kDa
Observed band size: 10 kDa
false
Exposure time: 103s
- Dot
Supplier Data
Dot Blot - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Dot blot analysis of CCL18 using ab300057 at 1 : 1000 (0.491 μg/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Exposure time : 3 minutes
Blocking and diluting buffer and concentration : 5% NFDM/TBST
- Dot
Supplier Data
Dot Blot - Anti-CCL18 antibody [EPR24781-84] (AB300057)
Dot blot analysis of CCL18 using ab300057 at 1 : 1000 (0.491 μg/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Exposure time : 5.5 seconds
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CCL18 plays an important role in modulating immune responses and recruiting immune cells to sites of inflammation. It is not part of a larger complex but works closely with other components of the immune system. CCL18 influences the activity of monocytes and the differentiation of T cells which are essential for mounting effective defense against pathogens. In inflammatory conditions increased CCL18 levels suggest its importance in controlling the magnitude and duration of immune responses.
Pathways
CCL18 is involved in the immune response and inflammatory pathways. It works particularly in chemokine signaling pathways and shares functional relations with proteins like CCR3 and CCR6 which act as receptors for various chemokines. The binding of CCL18 to these receptors on targeted cells facilitates the chemotaxis of immune cells steering the immune response to appropriate areas in the body where they are needed.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Adipocyte 13:2423723 PubMed39526504
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com